The characteristics and mechanism of dynamic changes of different components in microenvironment in regulating the progression of liver fibrosis
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 4
Abstract
The liver has diverse functions such as metabolism， detoxification， and immune defense， and the maintenance of hepatic microenvironment homeostasis is crucial for overall bodily health. The hepatic microenvironment consists of the components such as parenchymal cells， non-parenchymal cells， and non-cellular components. Chronic inflammatory responses induced by various etiological factors may promote the formation and progression of liver fibrosis. During the dynamic progression of liver fibrosis， from the early to advanced stages， various components within the hepatic microenvironment undergo a series of changes， which can promote the malignant progression of liver fibrosis. An in-depth exploration of the mechanisms underlying such changes in each component of the liver fibrosis microenvironment is of great significance for understanding the pathogenesis of liver fibrosis and discovering potential treatment strategies.
Authors and Affiliations
Huilan ZHAO, Zongxu LIU, Shumin LI, Zhifeng WANG, Minghui LIU, Qian SHENG, Kunbin KE, Xinan SHI
Keywords
Related Articles
- EP ID EP768494
- DOI 10.12449/JCH250423
- Views 12
- Downloads 0
Expert consensus on the sequential surgery following conversion therapy based on the combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma （2024 edition）
Up to half of patients with hepatocellular carcinoma （HCC） in China are diagnosed at an advanced stage and often with a dismal prognosis. More effective treatment strategies are mandatory. In recent years， the combina...
Effect of Qizhu prescription on a mouse model of non-alcoholic fatty liver disease incluced by high-fat， high-fructose， and high-cholesterol diet and its mechanism
[Objective] To investigate the therapeutic effect and mechanism of action of Qizhu prescription in mice with non-alcoholic fatty liver disease （NAFLD）. [Methods] A total of 60 male C57BL/6J mice were randomly divided i...
Unified consensus and evolution of the definition of acute-on-chronic liver failure： Seeking common ground while reserving differences
The concept of acute-on-chronic liver failure （ACLF） has been introduced for nearly 30 years， and with extensive research on its pathogenesis， diagnostic criteria， and treatment strategies， related consensus statem...
Impact of anticentromere antibody on the clinical features and prognosis of patients with primary biliary cholangitis
[Objective] To investigate the impact of anticentromere antibody （ACA） on the clinical features and prognosis of patients with primary biliary cholangitis （PBC） by comparing clinical classification， ursodeoxycholic...
An excerpt of EASL clinical practice guidelines on the management of hepatocellular carcinoma（2024 edition）
Liver cancer is the third leading cause of cancer-related deaths worldwide， among which hepatocellular carcinoma （HCC） accounts for approximately 90% in primary liver cancer. The advances in diagnostic and treatment t...